Skinvisible, Inc. (SKVI)
OTCMKTS · Delayed Price · Currency is USD
0.600
+0.034 (6.01%)
Sep 25, 2024, 4:00 PM EDT

Skinvisible Company Description

Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas.

Its non-dermatological formulations offer solutions for women’s health, pain management, and other markets.

The company’s flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products.

It also develops and licenses prescription and over-the-counter products to pharmaceutical and consumer goods companies; assists pharmaceutical clients in the early development of the formulations; and provides solutions to pharmaceutical companies by reformulating their products coming off patent with a new Invisicare patent, and new product benefits and line extensions.

The company was formerly known as Microbial Solutions, Inc. and changed its name to Skinvisible, Inc. in February 1999.

Skinvisible, Inc. was incorporated in 1998 and is based in Las Vegas, Nevada.

Skinvisible, Inc.
Country United States
Founded 1998
Industry Household & Personal Products
Sector Consumer Staples
Employees 2
CEO Terry Howlett

Contact Details

Address:
6320 South Sandhill Road
Las Vegas, Nevada 89120
United States
Phone 702 433 7154
Website skinvisible.com

Stock Details

Ticker Symbol SKVI
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number US8307032032
SIC Code 2844

Key Executives

Name Position
Terry H. Howlett President, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer and Director
Doreen McMorran Head of Business Development